EIPM's First Quarter External Newsletter
April 3, 2023
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our first quarterly external newsletter of 2023!
Thank you for signing up on our website to receive this newsletter, we hope you enjoy learning more about the important progress we’ve made towards our mission since last year.
EIPM Researcher Receives Grant to Study Prostate Cancer Evolution
March 22, 2023
Dr. Ekta Khurana, an associate professor of physiology and biophysics at Weill Cornell Medicine, has received a 3-year, $1.2 million grant from the United States Department of Defense to investigate how prostate cancer cells evolve to become resistant to hormone-blocking therapy. This work will contribute to further understanding prostate cancer and the development of effective targeted therapies for the disease.
Dr. Omar Abdul-Rahman Named EIPM Director of Clinical Genetics
February 23, 2023
Dr. Omar Abdul-Rahman, a leading specialist in pediatric genetic medicine, has been named chief of the Division of Medical Genetics in the Department of Pediatrics at Weill Cornell Medicine and NewYork-Presbyterian Komansky Children’s Hospital, effective March 1.
February 2023 EIPM Director's Memo
February 1, 2023
Dear Members of the Englander Institute,
We are thrilled to announce that applications are now being accepted for our very popular 6-week Summer Program for high school, college, and grad students, hosted by the EIPM and the Meyer Cancer Center! Students will actively participate in a range of projects related to cancer biology, precision medicine, cancer epidemiology, health disparities, academic research, computational biomedicine, journal clubs, professional development courses and more.
EIPM's Fourth Quarter External Newsletter
January 6, 2023
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our final quarterly external newsletter of 2022!
January 2023 EIPM Director's Memo
January 2, 2023
Dear Members of the Englander Institute,
As we begin the new year I’d like to thank everyone for their hard work, productivity, and dedication to our mission. It’s a great pleasure to work along side you, and I can hardly wait to see what the new year brings!
Enzyme That Protects Against Viruses Could Fuel Cancer Evolution
December 28, 2022
An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The finding suggests that the enzyme may be a potential target for future cancer treatments.
A Conversation with Grad Student Matt Wickersham
December 20, 2022
We are pleased to bring you this Conversation with Matt Wickersham, a graduate student who has worked in the lab of our Director Olivier Elemento, Ph.D., and who established the Weill Cornell Medicine Wellness Qlinic, the first student-run clinic focused on addressing the mental health disparities faced by the lesbian, gay, bisexual, transgender, and queer (LGBTQ+) communities in New York City. Matt was nominated for the Forbes 30 Under 30 list within the Social Justice category.
Harnessing Artificial Intelligence Technology for IVF Embryo Selection
December 19, 2022
An artificial intelligence algorithm can determine non-invasively, with about 70 percent accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell Medicine.
December 2022 EIPM Director's Memo
December 1, 2022
Dear Members of the Englander Institute,
As we begin the last month of the year I’d like to thank all of you for your hard work, productivity, and dedication to our mission. It’s a great pleasure to work along side you, and I can hardly wait to see what the new year brings for us!
This month’s EIPM Director’s Memo highlights new grants from the NIH, NCI, and the CTSC, impressive news media coverage of our work, speaking events at major conferences, and exciting publications in leading journals.